The CDC’s actions with this experimental jab have been downright criminal.
And that’s not a hyperbole.
For weeks, there has been a horrific trend of younger experimental COVID-19 vaccine recipients suffering from heart inflammation.
Yet, our medical overlords continued to allow 12-17 year olds to receive this medical experiment.
Today's headlines: FDA approves Pfizer vaccine for those aged 12-17; gas prices surge after pipeline ransomware attackhttps://t.co/uIPJgJil3g
— Charleston City Paper (@ChasCityPaper) May 11, 2021
The CDC called for an emergency meeting regarding the reports of myocarditis in young jab recipients.
But it appears they were in no rush to carry out the meeting.
— The HighWire (@HighWireTalk) June 17, 2021
The WHO recommends against routine COVID vaccination for children.
Meanwhile, the US CDC postponed their "emergency" meeting to celebrate the Juneteenth holiday. pic.twitter.com/bxa1Tl2FmM
— Rising serpent 🇺🇸 (@rising_serpent) June 22, 2021
That time when the CDC postponed an emergency meeting to discuss the maiming of children in order to have a picnic. This should age well. https://t.co/bGtS7Z4oFE
— the Arkivist (@the_Arkivist) June 18, 2021
But tragedies such as these are piling up by the hundreds.
Laura Mallozzi, whose 18-year-old developed myocarditis two days after second Pfizer vaccine, said she would never have connected dots between vaccine + son’s symptoms if she hadn’t read about condition in #TheDefender.
— Robert F. Kennedy Jr (@RobertKennedyJr) June 23, 2021
18 year old Isaiah Harris had a heart attack.
— ➐Z (@Zinnsgh0st) June 23, 2021
— ABC12WJRT (@ABC12WJRT) June 23, 2021
The CDC could ignore the issue no longer.
And they finally recognized the link to the experimental COVID-19 jabs:
CDC considers link between rare cases of heart inflammation, COVID-19 vaccines https://t.co/YVGODEfzwG
— WCTV Eyewitness News (@WCTV) June 22, 2021
CDC finally acknowledges that COVID vaccines cause heart inflammation in adolescents. Note, however, their choice of words: "likely association" and "mild inflammation" indicating an attempt to downplay the real danger to protect vaccination narrative: https://t.co/RDPjFTYpvj
— Ned Nikolov, Ph.D. (@NikolovScience) June 23, 2021
'Likely link' between rare heart inflammation and Pfizer, Moderna vaccines: CDC advisers https://t.co/6tuO56CUxW
— Toronto Sun (@TheTorontoSun) June 23, 2021
— NBC Chicago (@nbcchicago) June 23, 2021
A CDC safety group said there’s a “likely association” between a rare heart inflammatory condition in adolescents and young adults mostly after they’ve received their second Covid-19 vaccine shot, citing the most recent data available.
There have been more than 1,200 cases of a myocarditis or pericarditis mostly in people 30 and under who received Pfizer’s or Moderna’s Covid vaccine, according to a series of slide presentations published Wednesday for a meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices.Myocarditis is the inflammation of the heart muscle, while pericarditis is the inflammation of the membrane surrounding the heart.
“Clinical presentation of myocarditis cases following vaccination has been distinct, occurring most often within one week after dose two, with chest pain as the most common presentation,” said Dr. Grace Lee, who chairs the committee’s safety group. CDC officials are gathering more data to fully understand the potential risks, how to manage it and whether there are any long-term issues, she said.
The agency said there have been 267 cases of myocarditis or pericarditis reported after receiving one dose of the mRNA vaccines and 827 reported cases after two doses through June 11. There are 132 additional cases where the number of doses received is unknown, the CDC said.
Roughly 300 million of the shots had been administered as of June 11, the agency said.
“This is still a rare event,” Dr. Tom Shimabukuro said at the meeting. For both vaccines combined, there were 12.6 heart inflammation cases per million doses. The cases were more frequent among Moderna’s vaccine recipients at 19.8 cases per million versus eight cases per million for Pfizer’s, he said.
Daily Mail added input:
In a presentation released on Wednesday, the COVID-19 Vaccine Safety Technical (VaST) Work Group discussed nearly 500 reports of the heart inflammation, known as myocarditis, in vaccinated adults under age 30.
The group of doctors said he risk of myocarditis or pericarditis following vaccination with the mRNA-based shots in adolescents and young adults is notably higher after the second dose and in males
It comes as the Advisory Committee on Immunization Practices (ACIP) is set to meet this week to assess the possibility of a link between the heart condition and the mRNA vaccines.
According to the presentation, there have been 484 preliminary reports of myocarditis or pericarditis in young people under age 30 as of June 11.
So far, 323 have been confirmed by CDC and 148 are still under review.
In total, 309 patients were hospitalized, of which 295 were discharged and 79 percent have since recovered.
Nine patients are still hospitalized with two in intensive care units. There was no data available for five patients.
Males were much more likely to report heart inflammation after receiving a second dose than women.
As of June 11, there were 9.1 per million reported cases of myocarditis/pericarditis in females ages 12-to-17 compared to 66.7 per million in males of that age group.
What’s more, rates among females ages 18-to-24 and ages 25-to-29 were 5.5 per million and 2.6 per million respectively.
Ang males, rates were 56.3 per million for the 18-to-24 age group and 20.4 per million in the 25-to-29 group.
This type of heart inflammation can be caused by a variety of infections, including a bout of COVID-19, as well as certain medications.
With more than 90.6 million young Americans under age 30 who have received one or both doses of the Pfizer and Moderna vaccines, it means just 0.000534 percent of people who have been administered the shots have reported such an effect.
The ACIP will discuss the benefits of the mRNA vaccines versus the potential risk to adolescents and young adults from the heart condition, according to the agency’s agenda.
The group is not expected to cast a vote on any issues regarding the vaccine rollout, but may issue an update on vaccine safety, the odds of myocarditis and a risk-benefit of analysis of vaccines in teens and young adults.
The CDC earlier this month said it was still evaluating the risk from the condition and did not confirm a causal relationship between the vaccines and the heart issue.